Real-time interactive digital healthcare system for post-operative breast cancer patients: study protocol for a randomized controlled trial

[1] Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA: A Cancer Journal for Clinicians. 68 394-424

[2] Ferlay J(2013)A longitudinal study of shoulder and arm morbidity in breast cancer survivors 7 years after sentinel lymph node biopsy or axillary lymph node dissection Breast Cancer Research and Treatment. 139 125-134

[3] Soerjomataram I(2009)Shoulder-arm morbidity in patients with sentinel node biopsy and complete axillary dissection – data from a prospective randomised trial European Journal of Surgical Oncology (EJSO). 35 696-701

[4] Siegel RL(2000)Long-term morbidity following axillary dissection in breast cancer patients – clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors Breast Cancer Research and Treatment. 64 275-286

[5] Torre LA(2008)Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy Acta Oncologica. 47 835-842

[6] Jemal A(2004)Evaluation of arm and shoulder mobility and strength after modified radical mastectomy and radiotherapy Acta Oncologica. 43 280-283

[7] Kootstra JJ(2014)Functional morbidity following latissimus dorsi flap breast reconstruction J Adv Pract Oncol. 5 181-187

[8] Dijkstra PU(2018)The functional impact of breast reconstruction: an overview and update Plast Reconstr Surg Glob Open. 6 e1640-122

[9] Rietman H(2007)The efficacy of physiotherapy upon shoulder function following axillary dissection in breast cancer, a randomized controlled study BMC Cancer. 7 166-1886

[10] de Vries J(2017)Upper limb functionality and quality of life in women with five-year survival after breast cancer surgery Rev Bras Ginecol Obstet. 39 115-4303

[1] Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA: A Cancer Journal for Clinicians. 68 394-424

[2] Ferlay J(2013)A longitudinal study of shoulder and arm morbidity in breast cancer survivors 7 years after sentinel lymph node biopsy or axillary lymph node dissection Breast Cancer Research and Treatment. 139 125-134

[3] Soerjomataram I(2009)Shoulder-arm morbidity in patients with sentinel node biopsy and complete axillary dissection – data from a prospective randomised trial European Journal of Surgical Oncology (EJSO). 35 696-701

[4] Siegel RL(2000)Long-term morbidity following axillary dissection in breast cancer patients – clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors Breast Cancer Research and Treatment. 64 275-286

[5] Torre LA(2008)Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy Acta Oncologica. 47 835-842

[6] Jemal A(2004)Evaluation of arm and shoulder mobility and strength after modified radical mastectomy and radiotherapy Acta Oncologica. 43 280-283

[7] Kootstra JJ(2014)Functional morbidity following latissimus dorsi flap breast reconstruction J Adv Pract Oncol. 5 181-187

[8] Dijkstra PU(2018)The functional impact of breast reconstruction: an overview and update Plast Reconstr Surg Glob Open. 6 e1640-122

[9] Rietman H(2007)The efficacy of physiotherapy upon shoulder function following axillary dissection in breast cancer, a randomized controlled study BMC Cancer. 7 166-1886

[10] de Vries J(2017)Upper limb functionality and quality of life in women with five-year survival after breast cancer surgery Rev Bras Ginecol Obstet. 39 115-4303